LNTH on Nasdaq

Lantheus Holdings, Inc.

American in vitro and in vivo diagnostic substances company based in Billerica.

Price unavailable

Last updated Oct 18, 2026.

Overview

Compare with Quidel, NeoGen or Myriad Genetics, or pick any stock.

  • TickerLNTH on Nasdaq
  • IndustryIn Vitro & In Vivo Diagnostic Substances
  • HeadquartersBillerica, United States
  • Incorporated inDE2
  • Business address201 Burlington Road, South Building, Bedford, Ma 017302
  • Filer categoryLarge accelerated filer2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

61.1%Gross margin3
20.2%Operating margin3
15.2%Net margin3
0.5%Revenue growth, 20253
21.4%Return on equity3

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Pylarify brought in 39% of the revenue Lantheus Holdings, Inc. broke down this way in fiscal 2025.

  1. Pylarify$989.1M339%down 6% from 2024
  2. Radiopharmaceutical Oncology$989.1M339%down 7% from 2024
  3. Definity$330.2M313%up 4% from 2024
  4. Techne Lite$86.8M33%down 9% from 2024
  5. Strategic Partnerships And Other$59.4M32%up 56% from 2024
  6. Neuraceq [member]$51.4M32%
  7. License and Royalty Revenues$34.0M31%up 273% from 2024
  8. Other Precision Diagnostics$24.6M31%up 2% from 2024
Products and services by year
Products and services202320242025
Pylarify$851.3M$1.1B$989.1M
Radiopharmaceutical Oncology$854.4M$1.1B$989.1M
Definity$279.8M$317.8M$330.2M
Techne Lite$87.4M$95.5M$86.8M
Strategic Partnerships And Other$51.9M$38.2M$59.4M
Neuraceq [member]$0$0$51.4M
License and Royalty Revenues$33.4M$9.1M$34.0M
Other Precision Diagnostics$23.0M$24.2M$24.6M

Regions

United States brought in 95% of the revenue Lantheus Holdings, Inc. broke down this way in fiscal 2025.

  1. United States$1.5B395%down 2% from 2024
  2. Outside the United States$82.7M35%up 68% from 2024
Regions by year
Regions202320242025
United States$1.3B$1.5B$1.5B
Outside the United States$34.3M$49.2M$82.7M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue39¢$599.7M
  • Research and development12¢$177.3M
  • Other costs29¢$450.9M
  • Income tax5¢$80.2M
  • Profit15¢$233.6M

Out of $1.5B in revenue.3

Where each dollar of operating cash went, fiscal 2025

  • Share buybacks77¢$300.0M
  • Kept or used elsewhere23¢$90.1M

Out of $390.1M of cash from operations.3

Financial statements

Revenue45673$1.5B in 2025+344% since 2019
0$500.0M$1.0B$1.5B$2.0B2019: $347.3M$347.3M20192020: $339.4M$339.4M2020−2%2021: $425.2M$425.2M2021+25%2022: $935.1M$935.1M2022+120%2023: $1.3B$1.3B2023+39%2024: $1.5B$1.5B2024+18%2025: $1.5B$1.5B2025+1%
Gross profit45673$942.0M in 2025+439% since 2019
0$250.0M$500.0M$750.0M$1.0B2019: $174.8M$174.8M20192020: $138.8M$138.8M2020−21%2021: $187.7M$187.7M2021+35%2022: $581.7M$581.7M2022+210%2023: $709.5M$709.5M2023+22%2024: $988.3M$988.3M2024+39%2025: $942.0M$942.0M2025−5%
Operating income45673$310.8M in 2025+502% since 2019
-$200.0M0$200.0M$400.0M$600.0M2019: $51.7M$51.7M20192020: -$4.2M-$4.2M20202021: -$60.8M-$60.8M2021+1349%2022: $36.2M$36.2M20222023: $364.6M$364.6M2023+907%2024: $457.0M$457.0M2024+25%2025: $310.8M$310.8M2025−32%
Net income45673$233.6M in 2025+638% since 2019
-$100.0M0$100.0M$200.0M$300.0M$400.0M2019: $31.7M$31.7M20192020: -$13.5M-$13.5M20202021: -$71.3M-$71.3M2021+429%2022: $28.1M$28.1M20222023: $326.7M$326.7M2023+1064%2024: $312.4M$312.4M2024−4%2025: $233.6M$233.6M2025−25%

Every line of the income statement as filed: the last 3 fiscal years, latest first.3

Period ending2025-12-312024-12-312023-12-31
Noncash impairment$1.5B$1.5B$1.3B
Cost of goods sold$599.7M$545.6M$586.9M
Gross profit$942.0M$988.3M$709.5M
Sales and marketing$178.7M$177.9M$141.7M
General and administrative$275.1M$193.7M$125.5M
Research and development$177.3M$168.1M$77.7M
Total operating expenses$631.1M$539.7M$344.9M
Gain on sale of assets$0$8.4M$0
Operating income$310.8M$457.0M$364.6M
Interest expense$19.7M$19.7M$20.0M
Investment in equity securities - unrealized loss$8.6M$43.6M$0
Other income, net-$31.3M-$37.2M-$66.3M
Income before income taxes$313.8M$431.0M$410.9M
Income tax expense$80.2M$118.5M$84.3M
Net income$233.6M$312.4M$326.7M
Basic (in dollars per share)$3.46$4.52$4.79
Diluted (in dollars per share)$3.41$4.36$4.65
Basic (in shares)67.5M shares69.2M shares68.3M shares
Diluted (in shares)68.4M shares71.7M shares70.2M shares

Compare Lantheus Holdings, Inc. with another company

Leadership

Who has led Lantheus Holdings, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Jeffrey Allen Bailey2015
  2. Mary Anne Heino2015–2024
  3. Brian A. Markison2024–now

Chair

  1. Mary Anne Heino2025–now

President

  1. Jeffrey Allen Bailey2015
  2. Mary Anne Heino2015–2023
  3. Paul Blanchfield2023–now

Chief financial officer

  1. John W. Crowley2016–2018
  2. Robert J. Marshall Jr.2018–now

Chief operating officer

  1. Mary Anne Heino2015
  2. Paul Blanchfield2022–2023
20202025
Board members and other officers (39)

Former names

  • Lantheus MI Holdings, Inc.Mar 25, 2014 to May 23, 20142

Timeline

  1. Mar 5, 2024New chief executive Brian A. Markison becomes CEO11
  2. Aug 31, 2015New chief executive Mary Anne Heino becomes CEO13
  3. Jun 24, 2015New chief executive Jeffrey Allen Bailey becomes CEO12

Filings

510 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 65 major events, 270 insider forms, 40 large holders, 115 other. The latest 20:

  1. Oct 2, 2026DEFA14A EDGAR
  2. Oct 2, 20268-K EDGAR
  3. Sep 23, 2026SCHEDULE 13D/A EDGAR
  4. Sep 21, 2026DEFA14A EDGAR
  5. Sep 21, 20268-K EDGAR
  6. Sep 17, 2026DEFA14A EDGAR
  7. Sep 8, 2026DEFM14A EDGAR
  8. Sep 4, 2026SCHEDULE 13D/A EDGAR
  9. Sep 2, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  10. Sep 2, 2026S-8 EDGAR
  11. Aug 26, 2026PREM14A EDGAR
  12. Aug 19, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  13. Aug 19, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  14. Aug 13, 2026DEFA14A EDGAR
  15. Aug 13, 2026SCHEDULE 13G/A EDGAR
  16. Aug 6, 202610-Q EDGAR
  17. Aug 6, 20268-K EDGAR
  18. Aug 4, 2026DEFA14A EDGAR
  19. Aug 4, 2026DEFA14A EDGAR
  20. Aug 4, 20268-K EDGAR

The 510 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last three years, summarized. The full record is on SEC EDGAR.

Insider trades and holders

Large holders

Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 40 such filings since October 2021, the latest 10:

  1. Sep 23, 2026SCHEDULE 13D/A
  2. Sep 4, 2026SCHEDULE 13D/A
  3. Aug 13, 2026SCHEDULE 13G/A
  4. Jul 31, 2026SCHEDULE 13G
  5. May 15, 2026SCHEDULE 13G/A
  6. Apr 30, 2026SCHEDULE 13G
  7. Mar 27, 2026SCHEDULE 13G/A
  8. Feb 17, 2026SCHEDULE 13G/A
  9. Feb 12, 2026SCHEDULE 13G/A
  10. Feb 5, 2026SCHEDULE 13G/A

From Forms 4 and Schedules 13D and 13G filed with the SEC.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
BlackRock, Inc.8,397,642$931.6M0.0%+214,449
Farallon Capital Management, L.l.c.5,583,479$619.4M3.7%No change
Jupiter Topco LLC5,188,416$575.6M0.2%New
Fmr LLC3,879,971$430.4M0.0%−746,482
Vanguard Portfolio Management LLC3,238,471$359.3M0.0%+64,197
Vanguard Capital Management LLC2,932,214$325.3M0.0%+17,900
American Century Companies Inc2,816,547$312.5M0.1%+1,035,441
State Street Corp2,500,696$277.4M0.0%+70,893
Geode Capital Management, LLC1,841,367$204.3M0.0%+75,415
Morgan Stanley1,726,303$191.5M0.0%+79,840
Reinhart Partners, Llc.1,599,379$177.4M4.1%+34,501
Dimensional Fund Advisors LP1,466,260$162.7M0.0%+86,690
Assenagon Asset Management S.A.1,429,960$158.6M0.1%+1,297,641
Citadel Advisors LLC1,376,480$152.7M0.1%+1,091,936
Carmignac Gestion1,340,100$148.7M1.9%+12,100
Swedbank AB1,201,243$133.3M0.1%−27,500
Wellington Management Group Llp1,013,063$112.4M0.0%+244,213
Brown Advisory Inc915,683$101.6M0.2%+228,076
UBS Group AG835,494$92.7M0.0%−32,181
Northern Trust Corp818,394$90.8M0.0%+13,471
Goldman Sachs Group Inc814,096$90.3M0.0%+258,519
Marshall Wace, Llp773,978$85.9M0.1%+162,231
Deerfield Management Company, L.P.752,999$83.5M1.0%−75,000
Jacobs Levy Equity Management, Inc699,583$77.6M0.3%+121,938
Jpmorgan Chase & Co699,229$77.0M0.0%−40,244

13F reports cover disclosed long positions in U.S. stocks only.

Members of Congress who traded it

4 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.

DateMemberTradeAmountVs S&P sinceFiling
Jan 28, 2025Gilbert Ray Cisneros, Jr.Democratic, HouseBuy$1,001 - $15,000−17.9%Report
Jan 13, 2025Gilbert Ray Cisneros, Jr.Democratic, HouseBuy$1,001 - $15,000−27.1%Report
Jan 8, 2025Gilbert Ray Cisneros, Jr.Democratic, HouseBuy$1,001 - $15,000−24.6%Report
Jan 7, 2025Gilbert Ray Cisneros, Jr.Democratic, HouseBuy$1,001 - $15,000−27.9%Report

Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56